Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Menu
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

i2E Primary Source of Investment Capital

Get in Touch

[vc_row][vc_column][button size=”medium_rd_bt” url=”https://i2e.org/?na=view&id=27″]Return to Newsletter[/button][/vc_column][/vc_row][vc_row][vc_column width=”1/6″][/vc_column][vc_column width=”2/3″][vc_column_text]With more than $90 million of investment capital currently under management, i2E has been a primary source of concept, seed stage, start-up and early growth investment capital for Oklahoma’s emerging small businesses for two decades.

Our rigorous investment process has a reputation for producing companies that are well positioned for success in the marketplace. [/vc_column_text][vc_column_text]

FY2020 CLOSED INVESTMENTS totaling nearly $13 million

[/vc_column_text][/vc_column][vc_column width=”1/6″][/vc_column][/vc_row][vc_row][vc_column width=”1/3″][vc_column_text]

Aevus Precision Diagnostics, Oklahoma City
TBFP- $52,000
Aevus is building an AI powered prescription guidance platform (PrecisionRx)
for treating Type 2 Diabetes.
www.aevus.ai

[/vc_column_text][vc_column_text]

BlyncSync Technologies, LLC , Oklahoma City
TBFP – $50,000
BlyncSync offers a proprietary safety software platform designed to address the increasing problem of fatigue related accidents in the trucking industry.
www.blyncsync.com[/vc_column_text][vc_column_text]
Biolytx Pharmaceuticals, Oklahoma City

Seed Fund II – $170,000
Biolytx is developing a class of novel antibiotic peptides for use in treatments of ophthalmic wound care and serious hospital-acquired infections.
www.biolytx.com[/vc_column_text][vc_column_text]

Clear River Enviro, Edmond
Seed Fund II – $375,000
Clear River Enviro developed a proprietary hospital and surgery-based technology used to destroy unused DEA Controlled Substances (opioids) and EPA regulated pharmaceuticals.
www.rxdestruct.com[/vc_column_text][vc_column_text]

Dex-Pump, LLC, Oklahoma City
TBFP – $100,000
DEX-Pump has developed a patent-pending down-hole  pumping system for late in life horizontal wells that facilitates maximum economic recovery.[/vc_column_text][vc_column_text]

Grant Holster, LLC, Tulsa
TBFP – $35,000
Grant Holster is a cloud-based software platform that integrates project management with CRM, providing a best-practices grant management process.
www.grantholster.com
[/vc_column_text][/vc_column][vc_column width=”1/3″][vc_column_text]
Datebox, dba Happily, Inc., Oklahoma City

Seed Fund III – $275,000
Datebox is a monthly subscription service that provides a novel date night activity and related conversation topics for people in committed relationships.
www.thehappily.co[/vc_column_text][vc_column_text]

Linear Health Sciences, LLC, Norman
Accelerate, Angel Fund 2, Plains Venture Partners – $4,000,000
Linear Health Sciences is seeking FDA regulatory approval for a new break away technology for IV lines and catheter tubes.
www.linearsciences.com[/vc_column_text][vc_column_text]
MaxQ, Stillwater
Seed Fund II – $250,000
MaxQ is revolutionizing the shipping of temperature‐sensitive biologics with advanced breakthroughs in thermal insulation sciences.
www.packmaxq.com[/vc_column_text][vc_column_text]
Monscierge, Oklahoma City

Accelerate – $ 504,254
Monscierge is an international interactive software company that connects hotels and their guests through both in-room solutions and guest experience solutions.
www.whiteboardcrm.com[/vc_column_text][vc_column_text]
MS Pen Technologies, Inc., Tulsa

Seed Fund III – $500,000
The MasSpec Pen System is composed of a handheld and biocompatible pen-like device connected to a mass spectrometer that rapidly identifies the molecular profile of tissues during surgery.[/vc_column_text][vc_column_text]
Paldara, Inc., Broken Arrow

TBFP – $28,000
Paldara is an early stage biotech company focused on developing a time-release hydrogel solution containing antimicrobial material to address the problem of Catheter Associated Urinary Tract Infections.[/vc_column_text][/vc_column][vc_column width=”1/3″][vc_column_text]
PrivacyBrain, Oklahoma City

TBFP – $65,000
PrivacyBrain is a cyber security platform that removes sensitive employee information from the web.
www.privacybrain.com
[/vc_column_text][vc_column_text]
Progentec, Oklahoma City
Seed Fund III, Angel Fund II, Plains Venture Partners – $2,750,000
Progentec has developed a Lupus test to help physicians to diagnose lupus patients much earlier than symptoms appear, monitor disease activity, and predict flare-ups.
www.progentec.com
[/vc_column_text][vc_column_text]
Send-A-Ride, Oklahoma City
Seed Fund II – $750,000
SendaRide provides nonemergency medical transportation for the health care industry that is customized to each patient’s needs and provided through the Send-A-Ride’s own network of drivers.
www.sendaride.com[/vc_column_text][vc_column_text]
Ten-Nine Technologies, LLC, Tulsa

Seed Fund III, Angel Fund 2, Accelerate –
$2,500,000
Ten-Nine Technologies makes new materials for longer-lasting and more powerful batteries.
www.ten-ninetech.com[/vc_column_text][vc_column_text]
Virtuoso, LLC, Tulsa
TBFP – $60,000
Virtuoso is an embedded systems design workflow and content platform that allows custom embedded application hardware to be effortlessly virtualized.
www.virtuoso-software.com[/vc_column_text][vc_column_text]
WhiteBoard, Edmond
Seed Fund III – $250,000
Whiteboard Mortgage CRM provides a platform for high‐margin, low‐frequency sales personnel to create better relationships, and increase referrals by making it easy to stay in touch with contacts, clients and partners.
www.whiteboardcrm.com[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/6″][/vc_column][vc_column width=”2/3″][vc_column_text]

Here is a summary of our closed investments
for FY2020 and since inception.

[/vc_column_text][vc_column_text]

[/vc_column_text][vc_column_text] Since 1999, i2E has managed seven (7) early-stage investment funds, making 328 investments totaling over $76.5 million to 183 companies.

i2E also manages the SeedStep Angels, a network of Accredited Investors who provide capital, strategic advice and mentoring to emerging growth companies to help them succeed.  Typical investments range from $50,000-$500,000 with individual members making investment decisions.  Since the group’s inception in 2009, SeedStep Angels have invested in 56 companies.[/vc_column_text][vc_column_text][/vc_column_text][/vc_column][vc_column width=”1/6″][/vc_column][/vc_row]

Author

  • Sarah Graves Sarah Graves

More News

Loading...
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
Default Featured Image
OKBio
06.13.22

ECHO Investment Capital BIO

Read more
Default Featured Image
OKBio
06.13.22

AscendBioVentures BIO

Read more
Default Featured Image
OKBio
06.13.22

Dean McGee Eye Institute BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E